ALDH7A1 and prostate carcinoma: Several studies have been reported that dysregulation of PDE activities is associated with diverse tumors and carcinomas like chronic lymphocytic leukemia, glioblastoma, prostate cancer, breast cancer, adrenocortical tumor, etc. [24, 63, 64].